Masimo Debt to Equity Ratio 2007-2019 | MASI

Current and historical debt to equity ratio values for Masimo (MASI) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Masimo debt/equity for the three months ending September 30, 2019 was 0.00.
Masimo Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-09-30 $0.00B $1.11B 0.00
2019-06-30 $0.00B $1.04B 0.00
2019-03-31 $0.00B $1.01B 0.00
2018-12-31 $0.00B $0.97B 0.00
2018-09-30 $0.00B $0.91B 0.00
2018-06-30 $0.00B $0.83B 0.00
2018-03-31 $0.00B $0.77B 0.00
2017-12-31 $0.00B $0.72B 0.00
2017-09-30 $0.00B $0.72B 0.00
2017-06-30 $0.00B $0.71B 0.00
2017-03-31 $0.00B $0.63B 0.00
2016-12-31 $0.00B $0.56B 0.00
2016-09-30 $0.15B $0.33B 0.46
2016-06-30 $0.18B $0.30B 0.59
2016-03-31 $0.23B $0.27B 0.84
2015-12-31 $0.19B $0.28B 0.67
2015-09-30 $0.19B $0.27B 0.71
2015-06-30 $0.18B $0.28B 0.63
2015-03-31 $0.13B $0.33B 0.39
2014-12-31 $0.13B $0.31B 0.41
2014-09-30 $0.00B $0.28B 0.00
2014-06-30 $0.00B $0.32B 0.00
2014-03-31 $0.00B $0.35B 0.00
2013-12-31 $0.00B $0.33B 0.00
2013-09-30 $0.00B $0.31B 0.00
2013-06-30 $0.00B $0.29B 0.00
2013-03-31 $0.00B $0.28B 0.00
2012-12-31 $0.00B $0.28B 0.00
2012-09-30 $0.00B $0.31B 0.00
2012-06-30 $0.00B $0.30B 0.00
2012-03-31 $0.00B $0.28B 0.00
2011-12-31 $0.00B $0.28B 0.00
2011-09-30 $0.00B $0.30B 0.00
2011-06-30 $0.00B $0.28B 0.00
2011-03-31 $0.00B $0.26B 0.00
2010-12-31 $0.00B $0.23B 0.00
2010-09-30 $0.00B $0.25B 0.00
2010-06-30 $0.00B $0.23B 0.00
2010-03-31 $0.00B $0.21B 0.00
2009-12-31 $0.00B $0.29B 0.00
2009-09-30 $0.00B $0.27B 0.00
2009-06-30 $0.00B $0.25B 0.00
2009-03-31 $0.00B $0.24B 0.00
2008-12-31 $0.00B $0.22B 0.00
2008-09-30 $0.00B $0.21B 0.00
2008-06-30 $0.00B $0.19B 0.00
2008-03-31 $0.00B $0.17B 0.00
2007-12-31 $0.02B $0.15B 0.13
2007-09-30 $0.02B $0.14B 0.16
2007-06-30 $0.03B $-0.02B -1.67
2007-03-31 $0.00B 0.00
2006-09-30 $0.00B 0.00
2006-06-30 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.018B $0.858B
Masimo Corporation is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. They believe that Masimo SET helps clinicians monitor in excess of approximately million patients in healthcare settings around the world, and is the pulse oximeter technology used by the top hospitals. Masimo as a private `garage start-up` company because they convinced that the use of adaptive signal processing in the measurement of physiological parameters could solve the problems of low perfusion and motion, which had long plagued in-vivo monitoring and especially pulse oximetry, the measurement of the oxygen saturation of arterial blood. His solution, Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, was shown in a study comparing three pulse oximetry technologies to demonstrate the highest sensitivity and specificity in identifying desaturation events during conditions of motion and low perfusion.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $133.803B 27.71
Intuitive Surgical (ISRG) United States $68.096B 51.01
Edwards Lifesciences (EW) United States $48.065B 43.65
IDEXX Laboratories (IDXX) United States $24.085B 58.25
Fresenius Medical Care AG KGaA (FMS) Germany $23.905B 16.18
Olympus (OCPNY) Japan $22.142B 0.00
DexCom (DXCM) United States $21.412B 191.75
Teleflex (TFX) United States $17.593B 35.72
SONOVA HOLDING (SONVY) Switzerland $16.068B 0.00
Sysmex ADR (SSMXY) Japan $15.055B 40.53
Hologic (HOLX) United States $14.189B 22.02
Varian Medical Systems (VAR) United States $13.481B 31.96
STERIS (STE) Ireland $12.827B 28.33
ABIOMED (ABMD) United States $8.262B 44.96
SARTORIUS AG (SARTF) Germany $7.903B 69.37
Penumbra (PEN) United States $5.997B 195.17
Globus Medical (GMED) United States $5.235B 32.31
Integra LifeSciences Holdings (IART) United States $4.741B 20.37
Elekta AB (EKTAY) Sweden $4.519B 38.16
Tandem Diabetes Care (TNDM) United States $4.083B 0.00
Nevro (NVRO) United States $3.871B 0.00
Wright Medical Group (WMGI) Netherlands $3.848B 233.23
LivaNova (LIVN) United Kingdom $3.439B 24.76
Integer Holdings (ITGR) United States $2.915B 19.95
Cantel Medical (CMD) United States $2.874B 28.12
Nihon Kohden (NHNKY) Japan $2.475B 24.90
Glaukos (GKOS) United States $2.099B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.435B 28.25
Veracyte (VCYT) United States $1.343B 0.00
Silk Road Medical (SILK) United States $1.320B 0.00
Mesa Laboratories (MLAB) United States $1.157B 42.88
CryoLife (CRY) United States $1.124B 115.31
Natus Medical (NTUS) United States $1.106B 26.59
Tactile Systems Technology (TCMD) United States $1.087B 124.15
OPKO Health (OPK) United States $1.052B 0.00
Inogen (INGN) United States $1.028B 32.47
Luminex (LMNX) United States $1.014B 0.00
Accelerate Diagnostics (AXDX) United States $0.897B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.857B 28.48
OrthoPediatrics (KIDS) United States $0.797B 0.00
Intersect ENT (XENT) United States $0.781B 0.00
Pacific Biosciences Of California (PACB) United States $0.757B 0.00
Quotient (QTNT) Switzerland $0.654B 0.00
Si-Bone (SIBN) United States $0.547B 0.00
AngioDynamics (ANGO) United States $0.544B 24.95
AxoGen (AXGN) United States $0.483B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.440B 13.32
Alphatec Holdings (ATEC) United States $0.390B 0.00
Stereotaxis (STXS) United States $0.357B 0.00
Accuray (ARAY) United States $0.350B 0.00
Sientra (SIEN) United States $0.334B 0.00
Semler Scientific (SMLR) United States $0.327B 45.47
RTI Surgical (RTIX) United States $0.322B 87.20
ViewRay (VRAY) United States $0.315B 0.00
GenMark Diagnostics (GNMK) United States $0.310B 0.00
IRadimed (IRMD) United States $0.296B 41.63
CRH Medical (CRHM) Canada $0.284B 79.40
SeaSpine Holdings (SPNE) United States $0.283B 0.00
Fluidigm (FLDM) United States $0.275B 0.00
Restoration Robotics (VERO) Canada $0.168B 0.00
Spectral Diagnostics (EDTXF) Canada $0.128B 0.00
EDAP TMS S.A (EDAP) France $0.122B 32.23
Electromed (ELMD) United States $0.080B 28.82
Vermillion (VRML) United States $0.079B 0.00
Neuronetics (STIM) United States $0.078B 0.00
ConforMIS (CFMS) United States $0.070B 0.00
Sensus Healthcare (SRTS) United States $0.070B 0.00
Second Sight Medical Products (EYES) United States $0.067B 0.00
Apollo Endosurgery (APEN) United States $0.061B 0.00
T2 Biosystems (TTOO) United States $0.055B 0.00
Bioanalytical Systems (BASI) United States $0.053B 0.00
Helius Medical Technologies (HSDT) United States $0.039B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.036B 0.00
Neovasc (NVCN) Canada $0.032B 0.00
Ekso Bionics Holdings (EKSO) United States $0.028B 0.00
TransEnterix (TRXC) United States $0.027B 0.00
Ra Medical Systems (RMED) United States $0.026B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.025B 0.00
Xtant Medical Holdings (XTNT) United States $0.020B 0.00
Lianluo Smart (LLIT) China $0.019B 0.00
DarioHealth (DRIO) Israel $0.017B 0.00
American Shared Hospital Services (AMS) United States $0.015B 21.25
ReWalk Robotics (RWLK) Israel $0.015B 0.00
OBALON THERPTCS (OBLN) United States $0.014B 0.00
ENDRA Life Sciences (NDRA) United States $0.014B 0.00
Nanovibronix (NAOV) United States $0.013B 0.00
Allied Healthcare Products (AHPI) United States $0.012B 0.00
Avinger (AVGR) United States $0.010B 0.00
Dynatronics (DYNT) United States $0.008B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
InspireMD (NSPR) Israel $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Sunshine Heart Inc (CHFS) United States $0.002B 0.00
Viveve Medical (VIVE) United States $0.002B 0.00